Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway

American Journal of Pathology

Volumn 154, Issue 2, 1999, Pages 515-523

  Wielenga, Vera J M ^a   Smits, Ron ^b   Korinek, Vladimir ^c   Smit, Lia ^a   Kielman, Menno ^b   Fodde, Riccardo ^b   Clevers, Hans ^c   Pals, Steven T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD44V ANTIGEN; DNA BINDING PROTEIN; HERMES ANTIGEN; PROTEIN TCF 4; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DYSPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032912720     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65297-2     Document Type: Article

References (66)

1. American Cancer Society: Cancer Facts and Figures - 1994. Atlanta, GA, American Cancer Society, 1994
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-532
3. Nagase H, Nakamura Y: Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 1993, 2:425-434
4. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170
5. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsius S, Polakis P: Association of the APC gene product with β-catenin. Science 1993, 262:1731-1734
6. Gumbiner B: Generation and maintenance of epithelial cell polarity. Curr Opin Cell Biol 1990, 2:881-887
7. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedll R, Birchmeier W: Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996, 382:638-642
8. Molenaar M, van de Wetering M, Oosterwegel H, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H: Xtcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 1996, 86:391-399
9. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H: Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997, 275:1784-1787
10. Morin PJ, Sparks AB, Konnek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997, 275:1787-1790
11. Rubinfeld B, Bobbins P, El-Gamil M, Albert I, Porfini E, Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997, 275:1790-1792
12. Lesley J, Hyman R, Kincade PW: CD44 and its interactions with the extracellular matrix. Adv Immunol 1993 4:271-335
13. Stamenkovic I, Amiot M, Pesando JM, Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989, 56:1057-1063
14. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cell lines. Cell 1991, 65:13-24
15. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth K, Bell JL: Genomic structure of DNA encoding the lymphocyte horning receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992, 89:12160-12164
16. Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC: Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 1987, 105:983-990
17. Degrendle HC, Estress P, Siegelman MH: Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997, 278:672-675
18. Miyake K, Medina KL, Hayashi S, Ono S, Hamaoka T, Kincade PW: Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 1990, 171:477-488
19. Horst E, Meijer CJLM, Radaszkiewicz T, Ossekoppele GJ, van Krieken JHJM, Pals ST: Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM (CD54). Leukemia 1990, 4:595-599
20. Jalkanen S, Joensuu H, Söderström KO, Klemi P: Lymphocyte homing and clinical behaviour of non-Hodgkin's lymphoma. J Clin Invest 1991, 87:1835-1840
21. Sy MS, Guo YJ, Stamenkovic I: Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med 1992, 176:623-627
22. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993, 177:897-904
23. Stauder R, Eisterer W, Thaler J, Gunthert U: CD44 variant isoforms in non-Hodgkin's lymphomas: a new independent prognostic factor. Blood 1995, 85:2885-2899
24. Matsumara Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992, 340:1053-1058
25. Wielenga VJM, Heider KH, Offerhaus GJA, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993, 53:4754-4756
26. Kauffmann M, Heider KH, Sinn HP, Minckwitz G von, Ponta H, Herrlich P: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995, 345:615-619
27. Lacy BE, Underhill CB: The hyaluronate receptor is associated with actin filaments. J Cell Biol 1987, 105:1395-1404
28. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 1990, 61: 1303-1313
29. Kalomiris EL, Bourguignon LY: Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol 1988, 106:319-327
30. Tsukita S K, Oishi N, Sato J, Sagara A, Kawai, Tsukita S: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994, 126:391-394
31. Jackson D, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 1995, 128:673-685
32. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A: CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995, 128:687-698
33. van der Voort R, Taher TEI, Wielenga VJM, Prevo R, Smit C, David G, Hartmann G, Gherhardi E, Pals ST: Hepatocyte growth factor/scatter factor presentation by a CD44 splice variant promotes signaling through c-Met receptor tyrosine kinase in tumor cells J Biol Chem 1999 (in press)
34. Tanaka Y, Adams DH, Hubscher S, Shaw S: T-cell adhesion induced by proteoglycan immobilized MIP-1b. Nature 1993, 361:69-72
35. Heider KH, Hofmann M, Horst E, van den Berg F, Ponta H, Herrlich P, Pals ST: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993, 120:227-233
36. Mulder JWR, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offerhaus GJA, Pals ST: Colorectal cancer prognosis and expression of exon-v6 containing CD44 proteins. Lancet 1995, 344: 1470-1472
37. Kim H, Yang XL, Rosada C, Hamilton S, August T: CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 mutation. Arch Biochem Biophys 1994, 310:504-507
38. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM: Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol 1998, 33:303-309
39. Yamaguchi A, Urano T, Goi T, Saito M, Takeuchi K, Hirose K, Nakagawara G, Shiku H, Furukawa K: Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 1996, 14: 1122-1127
40. Imazeki F, Yokosuka O, Yamaguchi T, Ohto M, Isono K, Omata M: Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans. Gastroenterology 1996, 110:362-368
41. Wielenga VJM, van der Voort R, Mulder JWR, Kruyt PM, Weidema WF, Oosting J, Selderijk CA, van Krimpen C, Offerhaus GJA, Pals ST: CD44 splice variants as prognostic markers in colorectal cancer. Scand J Gastroenterol 1998, 33:82-87
42. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, Breukel C, Alt E, Lipkin M, Khan PM, Kucherlapati R: A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA, 1994, 91:8969-8973
43. -/- small intestine. Nature Genet 1998, 19:379-383
44. Heider KH, Sproll M, Susani S, Patzelt E, Beaumier P, Ostermann E, Ahorn H, Adolf GR: Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas. Cancer Immunol Immunother 1996, 43: 245-253
45. Weiss JM, Sleeman J, Renkl AC, Dittmar H, Termser CC, Taxis S, Howells N, Hofmann M, Kohler G, Schopf E, Ponta H, Herrlich P, Simon JC: An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol 1997, 137:1137-1147
46. van der Voort R, Taher TEI, Keehnen RMJ, Smit L, Groenink M, Pals ST: Paracrine regulation of germinal center B cell adhesion through the c-Met-hepatocyte growth factor/scatter factor pathway. J Exp Med 1997, 185:2121-2131
47. Jen J, Powell SM, Papadopoulos N, Smith K, Hamilton SR, Vogelstein B, Kinzler KW: Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994, 54:5523-5526
48. Smits R, Kartheuser A, Jagmohan-Changur S, Leblanc V, Breukel C, de Vries A, van Kranen H, van Krieken JH, Williamson S, Edelmann W, Kucherlapati R, Khan PM, Fodde R: Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis 1997, 18:321-327
49. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-Myc as a target of the APC pathway. Science 1998, 281:1509-1512
50. Furuta K, Zahurak M, Yang XL, Rosada C, Goodman SN, August JT, Hamilton SR: Relationship between CD44 expression and cell proliferation in epithelium and stroma of colorectal neoplasms. Am J Pathol 1996, 149:1147-1155
51. Moser AR, Dove WF, Roth KA, Gordon JI: The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 1992, 116:1517-1526
52. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I: Interaction between CD44 and hyaluronate is directely implicated in the regulation of tumor development. J Exp Med 1994, 180:53-66
53. Yu Q, Toole BP, Stamenkovic I: Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997, 186:1985-1996
54. Ruoslahti E, Yamaguchi Y: Proteoglycans as modulators of growth tactor activities. Cell 1991, 64:867-869
55. Schlessinger J, Lax I, Lemmon M: Regulation of growth factor activation by proteoglycans. What is the role of the low affinity receptors? Cell 1995, 83:357-360
56. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W: Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 1990, 111:2097-2108
57. Giordano S, Zhen Z, Medico E, Gaudino G, Galimi F, Comoglio PM: Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc Natl Acad Sci USA 1993, 90:649-653
58. Rong S, Segal S, Anver M, Resau JH, Vande Woude GF: Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 1994, 91:4731-4735
59. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, Plebani M, Gespach C, Comoglio PM: Overexpression and amplilication of the Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995, 1:147-154
60. Liu C, Park M, Tsao MS: Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene 1992, 7:181-185
61. Prat M, Narishman RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM: The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991, 49:323-328
62. Reichsman F, Smith L, Cumberledge S: Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction. J Cell Biol 1996, 135:819-827
63. Binari RC, Staveley BE, Johnson WA, Godavarti A, Sasisekharan R, Manoukian AS: Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling. Development 1997, 124: 2623-2632
64. Haerry TE, Heslip TR, Marsh JL, O'Connor MB: Defects in glucuronate biosynthesis disrupt Wingless signaling in Drosophila. Development 1997, 124:3055-3064
65. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C: Scatter factor/ hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993, 123:223-235
66. Kediger M: Growth and development of intestinal mucosa. Small Bowel Enterocyte Culture and Transplantation. Edited by Campbell FC. Austin, TX, RG Landes Co. 1994, pp 1-30